GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

SMS Pharmaceuticals SMSPHARMA.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

513.20

+2.94%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹8.83bn

FY2017FY2026

Net income

₹1.02bn

FY2017FY2026

Free cash flow

−₹713.3m

FY2017FY2026

Shareholders' equity

₹7.86bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₹8.83bn₹7.83bn₹7.09bn₹5.22bn₹5.20bn₹5.63bn₹4.12bn₹4.65bn₹4.65bn₹4.47bn
Gross profit₹2.99bn₹2.79bn₹2.29bn₹1.74bn₹2.36bn₹2.15bn₹1.40bn₹1.44bn₹1.45bn₹1.19bn
Research and development₹139.6m₹128.3m₹111.1m₹89.2m——————
Operating income₹1.33bn₹1.11bn₹851.1m₹227.3m₹821.8m₹988.4m₹579.0m₹708.3m₹734.7m₹556.2m
Net income₹1.02bn₹691.4m₹498.3m−₹70.6m₹622.2m₹625.3m₹315.7m₹400.5m₹317.5m₹284.9m
Diluted earnings per share10.887.635.87-0.837.357.463.734.733.743.04

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₹13.62bn₹11.53bn₹10.34bn₹8.80bn₹8.60bn₹8.12bn₹6.08bn₹5.59bn₹5.03bn₹4.93bn
Cash and short-term investments—₹414.0m₹360.4m₹73.8m₹465.8m₹404.2m₹95.4m₹148.0m₹126.3m₹122.9m
Total liabilities₹5.77bn₹5.13bn₹4.98bn₹4.19bn₹3.89bn₹4.02bn₹2.60bn₹2.37bn₹2.18bn₹2.38bn
Debt₹1.72bn₹2.64bn₹2.36bn₹2.16bn₹2.20bn₹2.23bn₹1.34bn₹1.33bn₹1.30bn₹1.34bn
Shareholders' equity₹7.86bn₹6.40bn₹5.36bn₹4.61bn₹4.70bn₹4.11bn₹3.48bn₹3.22bn₹2.84bn₹2.55bn
Shares outstanding94m91m85m85m85m84m85m85m85m94m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations₹592.2m₹817.1m₹501.2m₹224.5m₹450.6m₹904.5m₹397.1m₹497.6m₹318.1m₹734.7m
Capital spending−₹1.31bn−₹1.23bn−₹521.6m−₹299.2m−₹272.5m−₹1.52bn−₹427.3m−₹348.4m−₹85.5m−₹232.1m
Free cash flow−₹713.3m−₹416.7m−₹20.4m−₹74.7m₹178.1m−₹613.0m−₹30.2m₹149.2m₹232.6m₹502.7m
Dividends paid−₹35.5m−₹33.9m−₹25.4m−₹25.4m−₹25.4m−₹25.4m−₹42.3m−₹21.2m−₹20.4m−₹20.4m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹2.07bn₹2.38bn₹2.10bn₹2.42bn₹1.96bn₹2.48bn₹1.73bn₹1.97bn
Gross profit₹749.3m₹812.8m₹748.9m₹768.7m₹653.5m₹748.8m₹671.1m₹590.6m
Operating income₹309.6m₹297.7m₹336.3m₹383.4m₹296.2m₹321.7m₹245.1m₹228.4m
Net income₹209.1m₹327.1m₹234.7m₹253.1m₹204.9m₹203.2m₹182.4m₹141.0m
Diluted earnings per share2.233.492.592.792.262.242.151.66
Cash from operations———−₹100.0m—₹817.0m—−₹99.0m
Capital spending———−₹296.0m—−₹1.23bn—−₹711.0m
Free cash flow———−₹396.0m—−₹416.0m—−₹810.0m
Total assets—₹13.62bn—₹12.76bn—₹11.53bn—₹11.35bn
Cash and short-term investments———₹1.02bn—₹512.9m—₹207.3m
Debt—₹1.72bn—₹1.21bn—₹1.39bn—₹1.51bn
Shareholders' equity—₹7.86bn—₹7.29bn—₹6.40bn—₹5.64bn

Financial ratios

Data as of 21 Sept 2026

FY2026FY2025FY2024FY2023FY2022FY2021
Gross margin19.7%18.5%29.7%24.7%35.2%32.4%
Operating margin14.8%14.2%12.7%4.1%15.3%17.4%
Net margin11.5%8.8%7.0%-1.4%12.1%11.1%
Return on equity13.0%10.8%9.3%-1.5%13.2%15.2%
Return on assets7.5%6.0%4.8%-0.8%7.2%7.7%
Free cash flow yield3.9%4.4%2.6%1.3%1.7%6.2%
Revenue growth13.3%10.4%35.9%1.4%-8.2%37.7%
Earnings growth47.5%38.8%-805.8%-111.3%-0.5%98.0%
Current ratio1.81x1.71x1.61x1.61x1.92x1.58x
Debt to equity0.46x0.49x0.52x0.55x0.56x0.61x
Equity ratio57.7%55.5%51.9%52.4%54.7%50.5%
Interest coverage5.69x5.98x3.84x0.97x4.18x8.75x
R&D as a share of sales1.6%1.6%1.6%1.7%1.6%1.3%
Buybacks as a share of market value-3.5%-6.8%-0.2%0.0%-1.1%0.9%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue19.2%9.4%3.9%
Operating income80.4%6.2%6.7%
Net income—10.3%9.6%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin34.7%33.8%36.0%33.8%
Operating margin14.7%12.2%13.4%13.5%
Net margin10.3%7.4%8.5%8.0%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings48.440.740.7-142.311.317.231.68.618.034.0
Price to sales5.63.62.91.91.41.92.40.71.22.2

Dividends and splits

Per share, in the currency the company pays

Paid for 13 years. Last went ex-dividend on 22 Sept 2026.

FY2027FY2026FY2025FY2024FY2023FY2022FY2020FY2019
Paid in the year0.400.400.400.300.300.300.500.25
  • 10-for-1 split · 17 Dec 2015

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.